These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9639082)

  • 21. Bipolar and nonbipolar obsessive-compulsive disorder: a clinical exploration.
    Zutshi A; Kamath P; Reddy YC
    Compr Psychiatry; 2007; 48(3):245-51. PubMed ID: 17445518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth failure associated with the use of high dose prozac (fluoxetine hydrochloride) in a patient with type 1 diabetes mellitus.
    Frank GR; Navon RE
    J Pediatr Endocrinol Metab; 1999; 12(3):467-9. PubMed ID: 10821228
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-term treatment of obsessive-compulsive disorder after an acute response: a comparison of fluoxetine versus placebo.
    Romano S; Goodman W; Tamura R; Gonzales J
    J Clin Psychopharmacol; 2001 Feb; 21(1):46-52. PubMed ID: 11199947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of paroxetine in the treatment of obsessive-compulsive disorders.
    Kamijima K; Aoki M
    Expert Rev Neurother; 2006 Jul; 6(7):945-56. PubMed ID: 16831110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of third trimester fluoxetine exposure on the newborn.
    Goldstein DJ
    J Clin Psychopharmacol; 1995 Dec; 15(6):417-20. PubMed ID: 8748430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mood-related obsessive-compulsive symptoms in a patient with bipolar affective disorder.
    Gordon A; Rasmussen SA
    J Clin Psychiatry; 1988 Jan; 49(1):27-8. PubMed ID: 3335487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First manic/hypomanic episode in obsessive-compulsive disorder patients treated with antidepressants: A systematic review.
    Bertolín S; Alonso P; Segalàs C; Real E; Alemany-Navarro M; Soria V; Jiménez-Murcia S; Crespo JM; Menchón JM
    J Psychiatr Res; 2021 May; 137():319-327. PubMed ID: 33744511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antidepressant induced mania in obsessive compulsive disorder.
    Berk M; Koopowitz LF; Szabo CP
    Eur Neuropsychopharmacol; 1996 Mar; 6(1):9-11. PubMed ID: 8866932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of bipolar depression with twice-weekly fluoxetine: management of antidepressant-induced mania.
    Megna JL; Devitt PJ
    Ann Pharmacother; 2001 Jan; 35(1):45-7. PubMed ID: 11197585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluoxetine-induced mania in a patient with obsessive-compulsive disorder.
    Steiner W
    Am J Psychiatry; 1991 Oct; 148(10):1403-4. PubMed ID: 1897626
    [No Abstract]   [Full Text] [Related]  

  • 31. Lithium augmentation of fluoxetine in the treatment of OCD and major depression: a case report.
    Howland RH
    Can J Psychiatry; 1991 Mar; 36(2):154-5. PubMed ID: 1904303
    [No Abstract]   [Full Text] [Related]  

  • 32. Fluoxetine-induced mania in an Asian patient.
    Pae CU; Lee CU; Lee SJ; Lee C; Paik IH
    Psychiatry Clin Neurosci; 2004 Aug; 58(4):448-9. PubMed ID: 15298662
    [No Abstract]   [Full Text] [Related]  

  • 33. Ritanserin as adjunct to fluoxetine treatment of OCD patients with psychotic features.
    Bach M; Aigner M; Lenz G
    Pharmacopsychiatry; 1997 Jan; 30(1):28-9. PubMed ID: 9065968
    [No Abstract]   [Full Text] [Related]  

  • 34. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
    McDougle CJ; Goodman WK; Leckman JF; Barr LC; Heninger GR; Price LH
    J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness and mood conversion rate of short-term fluoxetine monotherapy in patients with rapid cycling bipolar II depression versus patients with nonrapid cycling bipolar II depression.
    Amsterdam JD; Luo L; Shults J
    J Clin Psychopharmacol; 2013 Jun; 33(3):420-4. PubMed ID: 23609385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An open clinical trial of fluoxetine in the treatment of obsessive-compulsive disorder.
    Fontaine R; Chouinard G
    J Clin Psychopharmacol; 1986 Apr; 6(2):98-101. PubMed ID: 3517083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluoxetine in obsessive compulsive disorder in adolescents.
    Bouvard M; Dugas M
    Int Clin Psychopharmacol; 1993; 8(4):307-10. PubMed ID: 8277152
    [No Abstract]   [Full Text] [Related]  

  • 38. Fluoxetine-induced akathisia: clinical and theoretical implications.
    Lipinski JF; Mallya G; Zimmerman P; Pope HG
    J Clin Psychiatry; 1989 Sep; 50(9):339-42. PubMed ID: 2549018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A second case of mania associated with fluoxetine.
    Turner SM; Jacob RG; Beidel DC; Griffin S
    Am J Psychiatry; 1985 Feb; 142(2):274-5. PubMed ID: 3871593
    [No Abstract]   [Full Text] [Related]  

  • 40. Double-blind study of adjuvant buspirone for fluoxetine-treated patients with obsessive-compulsive disorder.
    Grady TA; Pigott TA; L'Heureux F; Hill JL; Bernstein SE; Murphy DL
    Am J Psychiatry; 1993 May; 150(5):819-21. PubMed ID: 8480832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.